Founded in 2013 and based in the San Francisco Bay Area, Zymergen is a technology company unlocking the power of biology. We deliver better economics for products made from biology that are used across industries, bring new products to market faster, and develop novel products. We are engineering biology predictably, reliably and to a level of performance previously unattainable.
Want to join the team? Apply at www.zymergen.com/careers.
Funding Rounds (3) - $174.14MUpdate
Current Team (7)Update
Board Members and Advisors (2)Update
|Mar 15, 2017||Venture Capital Database - The State Of Synthetic Biology: Investors Placing Bets In Food, Biofuel, Healthcare, And More|
|Feb 3, 2017||Venture Capital Database - Synthetic Biology Game Changers: Startups Redesigning Biological Products|
|Dec 7, 2016||Techno Buffalo - Foxconn in “preliminary discussions” to invest billions in the US|
|Nov 22, 2016||Xconomy - The Convergence of Information Technology and the Life Sciences|
|Nov 3, 2016||Vator.tv - The top 15 healthcare deals of 2016|
|Oct 14, 2016||Venture Capital Database - Iconiq Capital Teardown: One Of Silicon Valley’s Most Influential Investors Has Had A Very Good Month|
|Oct 14, 2016||Business Wire - BizWireTV Video News: How are Top Brands Contributing to Hurricane Matthew Relief and New Forecast Predicts Record-Breaking Holidays Ahead for Tech|
|Oct 13, 2016||AgFunder News - Microbe Engineering Startup Zymergen Raises $130m Series B|
6121 Hollis St
Emeryville, CA 94608